LONG-TERM TREATMENT WITH SUBCUTANEOUS VEDOLIZUMAB IN CROHN’S DISEASE: INTERIM RESULTS FROM THE VISIBLE OPEN-LABEL EXTENSION STUDY

Silvio Danese  1     Severine Vermeire  2     Krisztina Kisfalvi  3     Wenwen Zhang  3     Shashi Adsul  4     Siddharth Bhatia  3     William Sandborn  5    
1 Humanitas Research Hospital and Humanitas University, Milan, Italy
2 University Hospital Leuven, Leuven, Belgium
3 Takeda, Cambridge, United States
4 Takeda, Zurich, Switzerland
5 University of California San Diego, La Jolla, United States

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing